Bubs Australia Limited reports a striking turnaround in FY25 with revenue up 29% to $102.5 million and net profit soaring 124% to $5.17 million, driven by strong US and China growth. The company awaits permanent FDA approval, a pivotal factor for its future trajectory.
Finexia Financial Group announces a strategic leadership reshuffle with the return of Neil Sheather as CEO and Managing Director, the appointment of Robert Spano as Executive Chairman, and a new CEO for its childcare subsidiary, Shared Beginnings.
